SCHEMBL7647833

SCHEMBL7647833

CCCNS(=O)(=O)c1cc2cc(P(=O)(O)OC(C)CC)c(=O)[nH]c2cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 2/20 0.32
PI4KB Q9UBF8 1/20 0.31
LMNA P02545 1/20 0.31
RECQL P46063 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 3/20 0.31
TP53 P04637 2/20 0.31
KDM4E B2RXH2 2/20 0.31
TSHR P16473 1/20 0.31
HPGD P15428 1/20 0.30
GSTO1 P78417 1/20 0.30
KCNA5 P22460 1/20 0.30
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652397 0.95 CA12 (0.35) POLBATMALDH1A1PI4KBHSD17B10
SCHEMBL7647655 0.93 ATM (0.34) POLBATMALDH1A1KDM4ETSHR
SCHEMBL7649184 0.91 GAA (0.35) POLBATMALDH1A1PI4KBRECQL
SCHEMBL7648022 0.90 GRIN1 (0.32) ATMHSD17B10TP53TSHRGRIN2D
SCHEMBL7647196 0.90 KMT2A (0.33) ATMHSD17B10TP53TSHRGSTO1
SCHEMBL7652294 0.89 ALDH1A1 (0.42) POLBALDH1A1LMNASMN1; SMN2NPSR1
SCHEMBL7645912 0.89 GSTO1 (0.34) ATMGSTO1GRIN2DGRIN3BGRIN1
SCHEMBL7646330 0.88 GRIN1 (0.31) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7648889 0.86 GRIN1 (0.32) GRIN1
SCHEMBL6926212 0.86 GRIN1 (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 POLB 2728/4885L3MBTL1 4403/4885ATM 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.